Should screening programs for carbapenemase-producing strains be implemented in ICU patients?
Enferm Infecc Microbiol Clin. 2017 Jun-Jul;35(6):331-332.
doi: 10.1016/j.eimc.2016.12.002.
Epub 2017 Jan 16.
[Article in
English,
Spanish]
Affiliation
- 1 Laboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, España. Electronic address: jesus.oteo@isciii.es.
No abstract available
MeSH terms
-
Bacterial Proteins / biosynthesis*
-
Cross Infection / drug therapy
-
Cross Infection / prevention & control*
-
Diagnostic Screening Programs* / organization & administration
-
Drug Resistance, Bacterial
-
Enterobacteriaceae / enzymology*
-
Enterobacteriaceae / isolation & purification
-
Enterobacteriaceae Infections / drug therapy
-
Enterobacteriaceae Infections / prevention & control*
-
Humans
-
Intensive Care Units*
-
beta-Lactamases / biosynthesis*
Substances
-
Bacterial Proteins
-
beta-Lactamases
-
carbapenemase